Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 4, 2010Journal of Medicinal ChemistryOpen Access

Novel Carbamates as Orally Active Acetylcholinesterase Inhibitors Found to Improve Scopolamine-Induced Cognition Impairment: Pharmacophore-Based Virtual Screening, Synthesis, and Pharmacology

View Full Paper
Ask AI
Bookmark
Share

Authors

SCShailendra S. ChaudhaeryKRKuldeep K. RoyUniversidad Politécnica de El SalvadorNSNeeraj Shakya

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chaudhaery et al. (2010) studied this question.

synapsesocial.com/papers/6a736a664e58671dcf6c330chttps://doi.org/10.1021/jm100573q
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CLINICAL AND COST-EFFECTIVENESS OF DONEPEZIL, RIVASTIGMINE, AND GALANTAMINE FOR ALZHEIMER'S DISEASE2002 · 79 citations
  2. 2Synthesis of Novel Phenserine-Based-Selective Inhibitors of Butyrylcholinesterase for Alzheimer's Disease1999 · 210 citations
  3. 3Design, Synthesis, and Biological Evaluation of Conformationally Restricted Rivastigmine Analogues2004 · 147 citations
  4. 4Structure−Activity Relationships of Acetylcholinesterase Noncovalent Inhibitors Based on a Polyamine Backbone. 4. Further Investigation on the Inner Spacer2008 · 58 citations
  5. 5Generation of Predictive Pharmacophore Models for CCR5 Antagonists:  Study with Piperidine- and Piperazine-Based Compounds as a New Class of HIV-1 Entry Inhibitors2003 · 73 citations